MNNCX
Price
$40.39
Change
+$0.22 (+0.55%)
Updated
Oct 8 closing price
Net Assets
533.47M
VTSAX
Price
$161.49
Change
+$1.03 (+0.64%)
Updated
Oct 8 closing price
Net Assets
2.02T
Interact to see
Advertisement

MNNCX vs VTSAX

Header iconMNNCX vs VTSAX Comparison
Open Charts MNNCX vs VTSAXBanner chart's image
Victory Munder Multi-Cap C
Price$40.39
Change+$0.22 (+0.55%)
VolumeN/A
Net Assets533.47M
Vanguard Total Stock Mkt Idx Adm
Price$161.49
Change+$1.03 (+0.64%)
VolumeN/A
Net Assets2.02T
MNNCX vs VTSAX Comparison Chart in %
View a ticker or compare two or three
VS
MNNCX vs. VTSAX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNNCX is a Buy and VTSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 2.02T vs. MNNCX (533M). VTSAX pays higher dividends than MNNCX: VTSAX (1.13) vs MNNCX (0.00). MNNCX was incepted earlier than VTSAX: MNNCX (27 years) vs VTSAX (25 years). MNNCX (2.76) is less costly to investors than VTSAX (0.04). MNNCX is a more actively managed with annual turnover of: 75.00 vs. VTSAX (2.00). MNNCX has a lower initial minimum investment than VTSAX: MNNCX (2500) vs VTSAX (3000). VTSAX annual gain was more profitable for investors over the last year : 16.78 vs. MNNCX (5.54). VTSAX return over 5 years is better than : 86.62 vs. MNNCX (20.56).
MNNCXVTSAXMNNCX / VTSAX
Total Expense Ratio2.160.045,400%
Annual Report Gross Expense Ratio2.760.046,900%
Fund Existence27 years25 years-
Gain YTD17.21613.853124%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets533M2.02T0%
Annual Yield % from dividends0.001.13-
Returns for 1 year5.5416.7833%
Returns for 3 years24.5681.2430%
Returns for 5 years20.5686.6224%
Returns for 10 years4.39230.252%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMPG4.320.02
+0.47%
Amplitech Group
SOLV72.430.27
+0.37%
Solventum Corp
FORTY142.150.30
+0.21%
Formula Systems (1985) Ltd
THRY11.09-0.14
-1.25%
Thryv Holdings
BDRX7.71-0.57
-6.88%
Biodexa Pharmaceuticals plc